Month: April 2018

Notizia

Business Consultant, Notizia, Pharma Consultant • One Comment

Positive Phase 1 data supports Cyclacel’s plans for CDK2/9 inhibitor CYC065 Cyclacel faced a big failure in for its late-stage drug for...

Read More

STAT INHIBITORS- Highly active Pipeline

Articles, Business Consultant, Pharma Consultant

Signal Transducer and Activator of Transcription (STAT ) is a family of cytoplasmic transcription factors comprising of 7 members-STAT1,...

Read More

Business Cocktail

Business Consultant, Pharma Consultant, The Business Cocktail

Cellectis successfully bags USD 164 million for Gene-editing and CAR-T programs After a rough journey in 2017, the road seems clear for...

Read More

Hepatic Encephalopathy- Lack of active pipeline products

Articles, Business Consultant, Pharma Consultant

Hepatic encephalopathy (HE) can be described as deterioration of brain function occurring due to accumulation of toxic substances in the...

Read More
Close